Aurion Biotech Launches Vyznova® (neltependocel) in Japan for the Treatment of Bullous Keratopathy of the Cornea
Business Wire India World’s first approved allogeneic cell therapy for corneal endothelial disease Prof. Shigeru Kinoshita, M.D., cell therapy inventor, successfully treats first patients Aurion Biotech, whose mission is to…